By Michele Maatouk
Date: Thursday 20 Nov 2025
(Sharecast News) - Abbott Laboratories said on Thursday that it has agreed to buy cancer diagnostics firm Exact Sciences for $23bn.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 0.00 |
| Closing Price Change | $ 0.09 |
| % Change | 0.00 % |
| 52 Week High | $103.45 |
| 52 Week Low | $40.31 |
| Volume | 0 |
| Shares Issued | 122.75m |
| Beta | 0.01 |
| RiskGrade | 275 |
| Strong Buy | 1 |
| Buy | 3 |
| Neutral | 17 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 21 |

You are here: research